SFRP1-Silencing GapmeR-Loaded Lipid-Polymer Hybrid Nanoparticles for Bone Regeneration in Osteoporosis: Effect of Dosing and Targeting Strategy DOI Creative Commons
Erik Briffault, Ricardo Reyes, Patricia García‐García

et al.

International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 12171 - 12188

Published: Nov. 1, 2024

Osteoporosis is a metabolic disorder characterized by the loss of bone mass and density. Nucleic acid-based therapies are among most innovative approaches for osteoporosis management, although their effective delivery to tissue remains challenge. In this work, SFRP1-silencing GampeR loaded-nanoparticles were prepared functionalized with specific moieties improve targeting and, consequently, therapeutic efficacy. would promote osteoblastic differentiation enhancing WNT/β-catenin pathway thus diminishing progression osteoporosis.

Language: Английский

Intervening with nanozymes in aging-related diseases: Strategies for restoring mitochondrial function DOI
Fanyong Yan, Dongyang Liu,

Baoshan Zhao

et al.

Biomaterials Advances, Journal Year: 2025, Volume and Issue: 169, P. 214193 - 214193

Published: Jan. 18, 2025

Language: Английский

Citations

2

Therapeutic strategy of biological macromolecules based natural bioactive compounds of diabetes mellitus and future perspectives: A systematic review DOI Creative Commons
Naiyer Shahzad, Abdullah R. Alzahrani,

Ibrahim Abdel Aziz Ibrahim

et al.

Heliyon, Journal Year: 2024, Volume and Issue: 10(2), P. e24207 - e24207

Published: Jan. 1, 2024

High blood glucose levels are a hallmark of the metabolic syndrome known as diabetes mellitus. More than 600 million people will have by 2045 global prevalence disease continues to rise. Contemporary antidiabetic drugs reduce hyperglycemia and its consequences. However, these come with undesirable side effects, so it's encouraging that research into plant extracts bioactive substances characteristics is on Natural remedies preferable conventional anti-diabetic since they safer for body, more affordable fewer potential adverse effects. Biological macromolecules such liposomes, niosomes, polymeric nanoparticles, solid lipid nanoemulsions metallic nanoparticles explored in this review. Current drug restrictions been addressed, effectiveness plant-based therapies has enhanced merits methods. Plant extracts' loading capacity carriers' stability primary obstacles developing nanocarriers. Hydrophilic, hydrophobic, amphiphilic covered, brief overview amphipathic features phospholipids, nanocarriers provided. Metallic nanoparticles' benefits attendant risks highlighted emphasize their efficiency treating hyperglycemia. Researchers interested loaded therapeutics may find current helpful

Language: Английский

Citations

12

Effect of nanoemulsion carbonated hydroxyapatite-statin administration on Acp 5 and Runx-2 expression during orthodontic relapse in rats DOI Creative Commons
Ananto Ali Alhasyimi, Niswati Fathmah Rosyida, Ika Dewi Ana

et al.

Journal of Oral Biology and Craniofacial Research, Journal Year: 2025, Volume and Issue: 15(1), P. 129 - 135

Published: Jan. 1, 2025

Retention is an essential element of orthodontic treatment. In the past two decades, numerous biological treatments have been developed to alleviate relapse. Pharmacologic bone modulation a viable approach mitigate The aim this investigation was determine whether administering nanoemulsion carbonated hydroxyapatite-statin (CHA-statin) would increase Runx-2 expression and decrease Acp 5 in rats experiencing experimental Forty-eight (n = 48) were assigned four groups: control, CHA, statin, CHA-statin, with 12 each group. A 30 g mesial traction applied for 7 days via closed-coil spring that connected first maxillary molar incisor. To maintain moved teeth, statin hydrogel, CHA-statin administered intrasulcularly every 3 period days. removal devices facilitated occurrence evaluated using immunohistochemistry method. collected data analysis variance post hoc tests, p < 0.05. significant reduction 5-positive cells group observed on 14 relapse movement compared other groups (p 0.05), whereas average expressions significantly higher than 1, 7, during phase 0.05). increased decreased expression, thereby potentially preventing rats.

Language: Английский

Citations

1

The absence of IRG1 exacerbates bone loss in a mouse model of ovariectomy‐induced osteoporosis by increasing osteoclastogenesis through the potentiation of NLRP3 inflammasome activation DOI
Fang Wang,

Yanqiao Liu,

Yanqin Zhao

et al.

International Immunopharmacology, Journal Year: 2025, Volume and Issue: 148, P. 114099 - 114099

Published: Jan. 26, 2025

Language: Английский

Citations

1

Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy DOI
Rupesh K. Gautam, Pooja Mittal, Rajat Goyal

et al.

Current Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 31(28), P. 4479 - 4494

Published: Aug. 1, 2024

Nanomedicine's application of nanotechnology in medicine holds tremendous potential for diagnosing and treating life-threatening diseases such as cancer. Unlike conventional therapies, nanomedicine offers a promising strategy to enhance clinical outcomes while minimizing severe side effects. The principle drug targeting enables specific delivery therapeutic agents their intended sites, making it more precise effective therapy. Combination strategies, the co-delivery chemotherapeutic drugs with nucleic acids or receptor-specific molecules, are being employed outcomes. Nanocarriers systems designed using these approaches offer resourceful anticancer Targeted via nanotechnology-based techniques has become an urgent need shown significant improvements implications, pharmacokinetics, specificity, reduced toxicity, biocompatibility. This review discusses extrapolation nanomaterials developing innovative novel Additionally, we explore role concepts research.

Language: Английский

Citations

3

Therapeutic efficacy of zoledronic acid combined with calcium and calcitriol in the treatment of senile osteoporosis in elderly patients DOI
Yi Zhang, Yuan Tian,

X. Chen

et al.

Inflammopharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: March 5, 2025

Language: Английский

Citations

0

A bone-targeting near-infrared luminescence nanocarrier facilitates alpha-ketoglutarate efficacy enhancement for osteoporosis therapy DOI Open Access

Chunan Cheng,

Zhenyu Xing,

Qian Hu

et al.

Acta Biomaterialia, Journal Year: 2023, Volume and Issue: 173, P. 442 - 456

Published: Nov. 19, 2023

Language: Английский

Citations

6

Advancements and Challenges in Aptamer-Based Therapeutics and Diagnostics Across Diverse Medical Domains: A Comprehensive Review DOI
Ahmed S.A. Ali Agha, Walhan Alshaer, Talal Aburjaı

et al.

Jordan Journal of Pharmaceutical Sciences, Journal Year: 2024, Volume and Issue: 17(2), P. 344 - 361

Published: June 25, 2024

Aptamers, which are single-stranded DNA or RNA molecules, increasingly recognized as important tools in diagnostics and therapeutics across various medical disciplines such oncology, respiratory diseases, neurological disorders. This review provides a comprehensive evaluation of the recent progress obstacles encountered field aptamer-based applications. Aptamers have shown promise oncology for early cancer detection targeted drug delivery, effectively reducing off-target effects. They also hold potential significantly impacting management conditions asthma Chronic Obstructive Pulmonary Disease (COPD) by selectively targeting cytokines regulating inflammatory response. In realm disorders, aptamers offer novel methods influencing gut-brain axis proposing approaches specific therapy. Despite these notable benefits, persistent challenges remain areas molecular stability, delivery mechanisms, economic viability. offers overview while exploring avenues future research.

Language: Английский

Citations

0

Breaking the vicious cycle of cellular senescence and ROS via a mitochondrial-targeted hydrogel for aged bone regeneration DOI Creative Commons
Liangmin Fu, Shan Wang, Na Zhang

et al.

Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 503, P. 158540 - 158540

Published: Dec. 11, 2024

Language: Английский

Citations

0

Biomacromolecules-based nanoparticle formulations for the treatment of osteoporosis: A bibliometric analysis DOI

Xiaonan Zhou,

Jiewen Deng, Huan Wang

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 282, P. 136483 - 136483

Published: Oct. 21, 2024

Language: Английский

Citations

0